Search Results - Delauche-Cavallier, M. C.

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine

    QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine by Delauche-Cavallier, M. C., Chaufour, S., Guérault, E., Lacroux, A., Murrieta, M., Wajman, A.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Lumbar disc herniation : computed tomography scan changes after conservative treatment of nerve root compression

    Lumbar disc herniation : computed tomography scan changes after conservative treatment of nerve root compression by DELAUCHE-CAVALLIER, M.-C, BUDET, C, LAREDO, J.-D, DEBIE, B, WYBIER, M, DORFMANN, H, BALLNER, I

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Clinical uroselectivity: evidence from patients treated with slow‐release alfuzosin for symptomatic benign prostatic obstruction

    Clinical uroselectivity: evidence from patients treated with slow‐release alfuzosin for symptomatic benign prostatic obstruction by BUZELIN, J.M., DELAUCHE‐CAVALLIER, M.C., ROTH, S., GEFFRIAUD‐RICOUARD, C., SANTONI, J.P.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Alfuzosin for benign prostatic hypertrophy

    Alfuzosin for benign prostatic hypertrophy by Jardin, A., Bensadoun, H., Delauche-Cavallier, M.C., Attali, P.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    QT interval monitoring during clinical studies with mizolastine, a new H 1 antihistamine

    QT interval monitoring during clinical studies with mizolastine, a new H 1 antihistamine by Delauche‐Cavallier, M. C., Chaufour, S., Guérault, E., Lacroux, A., Murrieta, M., Wajman, A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Alfuzosin for treatment of benign prostatic hypertrophy

    Alfuzosin for treatment of benign prostatic hypertrophy by Jardin, A., Bensadoun, H., Delauche-Cavallier, M.C., Attatli, P., The BPH-ALF Group

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Solitary plasmacytoma of the spine. Long‐term clinical course

    Solitary plasmacytoma of the spine. Long‐term clinical course by Delauche‐Cavallier, Marie C., Laredo, Jean D., Wybier, Marc, Bard, Michel, Le, Jeanne L., Darne, Bai L., Kuntz, Daniel, Ryckewaert, Antoine, Mazabraud, Andre

    Published in Cancer
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  8. 8
    Clinical uroselectivity: evidence from patients treated with slow release alfuzosin for symptomatic benign prostatic obstruction

    Clinical uroselectivity: evidence from patients treated with slow release alfuzosin for symptomatic benign prostatic obstruction by Buzelin, J M, Delauche Cavallier, M C, Martin, D, Angel, I

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Alfuzosin for treatment of benign prostatic hypertrophy. The BPH-ALF Group

    Alfuzosin for treatment of benign prostatic hypertrophy. The BPH-ALF Group by Jardin, A, Bensadoun, H, Delauche-Cavallier, M C, Attali, P

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: